160 related articles for article (PubMed ID: 33190136)
1. Magnetic Resonance Imaging May Be Able to Identify the Origin of Neuroendocrine Tumor Liver Metastases.
Barat M; Soyer P; Al Sharhan F; Terris B; Oudjit A; Gaujoux S; Coriat R; Hoeffel C; Dohan A
Neuroendocrinology; 2021; 111(11):1099-1110. PubMed ID: 33190136
[TBL] [Abstract][Full Text] [Related]
2. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
[TBL] [Abstract][Full Text] [Related]
3. Diffuse Bone Metastases in Pancreatic Neuroendocrine Tumor Shown on Octreoscan.
Adkins J; Lu Y
Clin Nucl Med; 2019 Mar; 44(3):257-258. PubMed ID: 30624276
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.
van der Pol CB; Lee S; Tsai S; Larocque N; Alayed A; Williams P; Schieda N
Abdom Radiol (NY); 2019 Mar; 44(3):992-999. PubMed ID: 30603880
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of
Ortiz S; García JR; Riera E; Soler M; Compte Montañez A; Valls E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):244-245. PubMed ID: 32089469
[No Abstract] [Full Text] [Related]
6. Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization.
Luo Y; Ameli S; Pandey A; Khoshpouri P; Ghasabeh MA; Pandey P; Li Z; Hu D; Kamel IR
Eur Radiol; 2019 Nov; 29(11):5804-5812. PubMed ID: 31073860
[TBL] [Abstract][Full Text] [Related]
7. Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?
Lavelle LP; O'Neill AC; McMahon CJ; Cantwell CP; Heffernan EJ; Malone DE; Daly L; Skehan SJ
Clin Radiol; 2016 Sep; 71(9):863-8. PubMed ID: 27345612
[TBL] [Abstract][Full Text] [Related]
8. Gastroenteropancreatic neuroendocrine tumors: impact of consistent contrast agent selection on radiologists' confidence in hepatic lesion assessment on restaging MRIs.
Balthazar P; Shinagare AB; Tirumani SH; Jagannathan JP; Ramaiya NH; Khorasani R
Abdom Radiol (NY); 2018 Jun; 43(6):1386-1392. PubMed ID: 28840281
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging.
Lyu HL; Cao JX; Wang HY; Wang ZB; Hu MG; Ma L; Wang YW; Ye HY
Abdom Radiol (NY); 2018 Oct; 43(10):2712-2720. PubMed ID: 29500651
[TBL] [Abstract][Full Text] [Related]
10. MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection.
Sun HT; Zhang SL; Liu K; Zhou JJ; Wang XX; Shen TT; Song XH; Guo YL; Wang XL
J Magn Reson Imaging; 2019 Aug; 50(2):397-409. PubMed ID: 30589158
[TBL] [Abstract][Full Text] [Related]
11. Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
Li J; Liang L; Yu H; Shen Y; Hu Y; Hu D; Tang H; Li Z
Magn Reson Imaging; 2019 Jan; 55():52-59. PubMed ID: 30240758
[TBL] [Abstract][Full Text] [Related]
12. Measurement variability of liver metastases from neuroendocrine tumors on different magnetic resonance imaging sequences.
Lestra T; Kanagaratnam L; Mulé S; Janvier A; Brixi H; Cadiot G; Dohan A; Hoeffel C
Diagn Interv Imaging; 2018 Feb; 99(2):73-81. PubMed ID: 29339222
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors.
Denecke T; Baur AD; Ihm C; Steffen IG; Tischer E; Arsenic R; Pascher A; Wiedenmann B; Pavel M
Eur J Radiol; 2013 Oct; 82(10):e550-5. PubMed ID: 23891296
[TBL] [Abstract][Full Text] [Related]
15. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
Kumbasar B; Kamel IR; Tekes A; Eng J; Fishman EK; Wahl RL
Abdom Imaging; 2004; 29(6):696-702. PubMed ID: 15162235
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance Imaging of Neuroendocrine Tumor Hepatic Metastases: Does Hepatobiliary Phase Imaging Improve Lesion Conspicuity and Interobserver Agreement of Lesion Measurements?
Morse B; Jeong D; Thomas K; Diallo D; Strosberg JR
Pancreas; 2017 Oct; 46(9):1219-1224. PubMed ID: 28902795
[TBL] [Abstract][Full Text] [Related]
18. A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors.
Maxwell JE; Sherman SK; Stashek KM; O'Dorisio TM; Bellizzi AM; Howe JR
Surgery; 2014 Dec; 156(6):1359-65; discussion 1365-6. PubMed ID: 25456909
[TBL] [Abstract][Full Text] [Related]
19. Value of hepatocellular phase imaging after intravenous gadoxetate disodium for assessing hepatic metastases from gastroenteropancreatic neuroendocrine tumors: comparison with other MRI pulse sequences and with extracellular agent.
Tirumani SH; Jagannathan JP; Braschi-Amirfarzan M; Qin L; Balthazar P; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2018 Sep; 43(9):2329-2339. PubMed ID: 29470627
[TBL] [Abstract][Full Text] [Related]
20. The influence of somatostatin receptor scintigraphy during preoperative staging of non-functioning pancreatic neuroendocrine tumours.
Jilesen AP; Hoefnagel SJ; Busch OR; Bennink RJ; Gouma DJ; Nieveen van Dijkum EJ
Clin Radiol; 2016 Jun; 71(6):537-42. PubMed ID: 27016111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
